Pharmaceuticals, Biotechnology and Life Sciences
LAWRENCEVILLE, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated…
Announced acquisition of CT-95, a mesothelin x CD3 bispecific antibody Claudio Dansky Ullmann, M.D. named Chief Medical Officer Cash and…
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,…
Delivered Robust Revenue Performance, Fueled by Exceptional Commercial Execution and Early Success of the U.S. AGAMREE® Product Launch Reported Record…
Conference Call Scheduled for Wednesday, August 14, 2024 at 9:00 AM ETPORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) — ImmuCell…
Revolution Medicines to hold webcast today at 4:30 p.m. Eastern TimeREDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — Revolution…
Reported dose-dependent antitumor clinical activity in patients with relapsed/refractory triple-negative breast cancer from the Phase 1 trial of LYL797, a…
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA…
GAITHERSBURG, Md., Aug. 07, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing…
Full Enrollment Achieved in Global Phase 2 Hepatitis C Virus (HCV) Study; Complete SVR12 Results Expected 4Q’24 Bemnifosbuvir and Ruzasvir…